References
- Castleman B, Towne V. Case records of the Massachutes general Hospital: case no.40231. N Engl J Med 1954; 250: 1001–1005
- Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi's sarcoma-associated herpervirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276–1280
- Yoshizaki K, Matsuda T, Nishimoto H, Kuritani T, Taheo L, Aozasa K, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360–1367
- Dham A, Peterson B A. Castleman disease. Curr Opin Hematol 2007; 14: 354–359
- Dupin N, Diss T L, Kellam P, Tuliez M, Du MQ, Sicard D, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastyc lymphoma. Blood 2000; 95: 1406–1412
- Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, et al. Long-term remission of Kaposi sarcoma-associated herpes-virus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 2001; 98: 3473–3475
- Marcelin A G, Aaron L, Mateus C, Gyan E, Gorin I, Viard JP, et al. Rituximab therapy for Castleman disease. Blood 2003; 102: 2786–2798
- Bower M, Powles T, Williams S, Davis TN, Atkins M, Montoto S, et al. Brief communication: rituximab in HIV- associated multicentric Castleman disease. Ann Intern Med 2007; 147: 836–839
- Gerard L, Berezne A, Galicier L, Meignin V, Obadia M, De Castro N, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS CastlemaB Trial. J Clin oncol 2007; 25: 3350–3356
- Casquero A, Barroso A, Fernandez Guerrero M L, Gorgolas M. Use of rituximab as salvage therapy for HIV-associated multicentric Castleman disease. Ann Hematol 2006; 85: 185–187
- Ide M, Kawachi Y, Izumi Y, Kasagi K, Ogino T, et al. Long term remission in HIV-negative patients with multicentric Castleman's disease using rituximab. Eur J Hematol 2006; 76: 119–123
- Ocio E M, Sanchez-Gujio F M, Diez-Campelo M, Castilla C, Blanco OJ, Caballero D, et al. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena. Am J Hematol 2005; 78: 302–305
- Cervera Grau J M, Galiana Esquerdo G, Llorca Ferrandiz C, Briceno Garcia H, Diaz Castellano M, Ferriz Moreno P. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20. Clin Trans Oncol 2006; 8: 540–541
- Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 1997; 6: 1517–1522